Immunomodulation in non-alcoholic fatty liver disease: exploring mechanisms and applications
Non-alcoholic fatty liver disease (NAFLD) exhibits increased lipid enrichment in hepatocytes. The spectrum of this disease includes stages such as nonalcoholic simple fatty liver (NAFL), nonalcoholic steatohepatitis (NASH), and liver fibrosis. Changes in lifestyle behaviors have been a major factor...
Main Authors: | Ziwei Guo, Qinjuan Wu, Pengfei Xie, Jiuchong Wang, Wenliang Lv |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2024-01-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2024.1336493/full |
Similar Items
-
Macrophages and the development and progression of non-alcoholic fatty liver disease
by: Bader Alabdulaali, et al.
Published: (2023-06-01) -
Dynamics of Liver Macrophage Subsets in a Novel Mouse Model of Non-Alcoholic Steatohepatitis Using C57BL/6 Mice
by: Nana Makiuchi, et al.
Published: (2023-09-01) -
Roles of Macrophages in Advanced Liver Fibrosis, Identified Using a Newly Established Mouse Model of Diet-Induced Non-Alcoholic Steatohepatitis
by: Yuki Tada, et al.
Published: (2022-10-01) -
Hepatic Macrophages as Targets for the MSC-Based Cell Therapy in Non-Alcoholic Steatohepatitis
by: Irina V. Kholodenko, et al.
Published: (2023-11-01) -
Heterogeneous population of macrophages in the development of non-alcoholic fatty liver disease
by: Ye Eun Cho, et al.
Published: (2023-03-01)